JW LIFESCIENCE CORPORATION (234080) Stock Statistics & Valuation Metrics

JW LIFESCIENCE CORPORATION has a market cap or net worth of $162.74B. The enterprise value is $199.73B.

Market Cap

$162.74B

Enterprise Value

$199.73B

JW LIFESCIENCE CORPORATION has 15,834,554 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding

15,834,554

Owned by Insiders

―

Owned by Institutions

0.58%

JW LIFESCIENCE CORPORATION’s return on equity (ROE) is 0.13 and return on invested capital (ROIC) is 10.60%.

Return on Equity (ROE)

0.13

Return on Assets (ROA)

0.09

Return on Invested Capital (ROIC)

10.60%

Return on Capital Employed (ROCE)

0.14

Revenue Per Employee

808.24M

Profits Per Employee

89.67M

Employee Count

319

Asset Turnover

0.81

Inventory Turnover

5.95

The current PE Ratio of JW LIFESCIENCE CORPORATION is 6.25. JW LIFESCIENCE CORPORATION’s PEG ratio is -0.13.

PE Ratio

6.25

PS Ratio

0.64

PB Ratio

0.73

Price to FCF

4.58

Price to Operating Cash Flow

3.47

PEG Ratio

-0.13

In the last 12 months, JW LIFESCIENCE CORPORATION had revenue of 257.83B and earned 28.61B in profits. Earnings per share was 1847.38.

Revenue

257.83B

Gross Profit

69.77B

Operating Income

33.30B

Pretax Income

31.75B

Net Income

28.61B

EBITDA

51.41B

Earnings Per Share (EPS)

1847.38

In the last 12 months, operating cash flow was 47.97B and capital expenditures -12.46B, giving a free cash flow of 35.51B billion.

Operating Cash Flow

47.97B

Free Cash Flow

35.51B

Free Cash Flow per Share

2242.78

JW LIFESCIENCE CORPORATION pays an annual dividend of ―, resulting in a dividend yield of 5.23%

Dividend Per Share

―

Dividend Yield

5.23%

Payout Ratio

N/A

Free Cash Flow Yield

21.82%

Earnings Yield

15.63%

Beta

0.07

52-Week Price Change

-21.86%

50-Day Moving Average

10934.60

200-Day Moving Average

11757.75

Relative Strength Index (RSI)

38.33

Average Volume (3m)

16.93K

JW LIFESCIENCE CORPORATION upcoming earnings date is Nov 16, 2026, TBA (Not Confirmed).

Last Earnings Date

Aug 14, 2026

Next Earnings Date

Nov 16, 2026

Ex-Dividend Date

―

JW LIFESCIENCE CORPORATION as a current ratio of 1.05, with Debt / Equity ratio of 22.93%

Current Ratio

1.05

Quick Ratio

0.67

Debt to Market Cap

0.25

Net Debt to EBITDA

0.82

Interest Coverage Ratio

11.74

In the past 12 months, JW LIFESCIENCE CORPORATION has paid 3.14B in taxes.

Income Tax

3.14B

Effective Tax Rate

0.10

JW LIFESCIENCE CORPORATION EV to EBITDA ratio is 3.59, with an EV/FCF ratio of 5.24.

EV to Sales

0.73

EV to EBITDA

3.59

EV to Free Cash Flow

5.24

EV to Operating Cash Flow

3.88

JW LIFESCIENCE CORPORATION has $9.00B in cash and marketable securities with $32.37B in debt, giving a net cash position of -$23.36B billion.

Cash & Marketable Securities

$9.00B

Total Debt

$32.37B

Net Cash

-$23.36B

Net Cash Per Share

-$1,475.30

Tangible Book Value Per Share

$9,489.53

Gross margin is 27.45%, with operating margin of 13.14%, and net profit margin of 10.26%.

Gross Margin

27.45%

Operating Margin

13.14%

Pretax Margin

12.61%

Net Profit Margin

10.26%

EBITDA Margin

20.42%

EBIT Margin

13.14%

The average price target for JW LIFESCIENCE CORPORATION is ―, which is 11.43% higher than the current price. The consensus rating is ―

Price Target

―

Price Target Upside

―

Analyst Consensus

―

Analyst Count

―

Revenue Growth Forecast

1.00%

EPS Growth Forecast

-47.42%

Smart Score

―

AI Score

69